ArticleNPJ Regenerative medicine2022

Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson's disease.

Benjamin M Hiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.